Your browser doesn't support javascript.
loading
The use of dose quantities in radiological protection: ICRP publication 147 Ann ICRP 50(1) 2021.
Harrison, J D; Balonov, M; Bochud, F; Martin, C J; Menzel, H-G; Smith-Bindman, R; Ortiz-López, P; Simmonds, J R; Wakeford, R.
Afiliación
  • Harrison JD; Faculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, United Kingdom.
  • Balonov M; Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Didcot, Oxon OX11 0RQ, United Kingdom.
  • Bochud F; Research Institute of Radiation Hygiene, 197101 St. Petersburg, Russia.
  • Martin CJ; Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Menzel HG; Department of Clinical Physics, University of Glasgow, Glasgow G12 8QQ, United Kingdom.
  • Smith-Bindman R; International Commission on Radiation Units and Measurements, Heidelberg, Germany.
  • Ortiz-López P; Department of Radiology and Biomedical Imaging, University of California, San Francisco, United States of America.
  • Simmonds JR; Retired from the International Atomic Energy Agency, Vienna, Austria.
  • Wakeford R; Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Didcot, Oxon OX11 0RQ, United Kingdom.
J Radiol Prot ; 41(2)2021 06 01.
Article en En | MEDLINE | ID: mdl-33571972
ABSTRACT
The International Commission on Radiological Protection has recently published a report (ICRP Publication 147;Ann. ICRP50, 2021) on the use of dose quantities in radiological protection, under the same authorship as this Memorandum. Here, we present a brief summary of the main elements of the report. ICRP Publication 147 consolidates and clarifies the explanations provided in the 2007 ICRP Recommendations (Publication 103) but reaches conclusions that go beyond those presented in Publication 103. Further guidance is provided on the scientific basis for the control of radiation risks using dose quantities in occupational, public and medical applications. It is emphasised that best estimates of risk to individuals will use organ/tissue absorbed doses, appropriate relative biological effectiveness factors and dose-risk models for specific health effects. However, bearing in mind uncertainties including those associated with risk projection to low doses or low dose rates, it is concluded that in the context of radiological protection, effective dose may be considered as an approximate indicator of possible risk of stochastic health effects following low-level exposure to ionising radiation. In this respect, it should also be recognised that lifetime cancer risks vary with age at exposure, sex and population group. The ICRP report also concludes that equivalent dose is not needed as a protection quantity. Dose limits for the avoidance of tissue reactions for the skin, hands and feet, and lens of the eye will be more appropriately set in terms of absorbed dose rather than equivalent dose.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Protección Radiológica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Radiol Prot Asunto de la revista: RADIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Asunto principal: Protección Radiológica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Radiol Prot Asunto de la revista: RADIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido